Mediolanum International Funds’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.2M Buy
159,825
+7,836
+5% +$522K 0.1% 213
2026
Q1
$9.41M Sell
151,989
-34,918
-19% -$2.43M 0.1% 210
2025
Q4
$12.5M Buy
186,907
+72,185
+63% +$4.67M 0.13% 188
2025
Q3
$7.62M Sell
114,722
-3,780
-3% -$299K 0.08% 225
2025
Q2
$10.2M Sell
118,502
-31,091
-21% -$2.44M 0.12% 177
2025
Q1
$10.1M Sell
149,593
-3,633
-2% -$296K 0.14% 167
2024
Q4
$11.9M Buy
153,226
+25,501
+20% +$1.89M 0.15% 143
2024
Q3
$8.58M Buy
127,725
+20,337
+19% +$1.67M 0.12% 177
2024
Q2
$11.5M Buy
107,388
+8,153
+8% +$1.03M 0.19% 111
2024
Q1
$13.8M Buy
+99,235
New +$12.5M 0.22% 97

Other funds holding DXCM

Mediolanum International Funds's DXCM Position: Q2 2026 in Review

Mediolanum International Funds increased its DexCom (DXCM) stake by 5.2% in Q2 2026, buying an estimated $522K and bringing the position to 159,825 shares worth $11.2M. The position accounts for 0.1% of the portfolio, ranked #213.

Mediolanum International Funds first reported a position in DXCM in Q1 2024 and has held it in 10 quarters since. The position peaked at $13.8M in Q1 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Mediolanum International Funds held 159,825 shares of DexCom worth $11.2M as of Q2 2026.
  • Mediolanum International Funds bought 7,836 DexCom shares in Q2 2026, an estimated $522K.
  • DexCom made up 0.1% of Mediolanum International Funds's portfolio in Q2 2026, its #213 holding.
  • Mediolanum International Funds first reported a position in DexCom in Q1 2024 and has held it in 10 quarters since.
  • Mediolanum International Funds's DexCom position peaked at $13.8M in Q1 2024.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Mediolanum International Funds's 13F filing for Q2 2026, filed 23 Jul 2026.